Department of Otolaryngology-Head and Neck Surgery, Loyola Stritch School of Medicine, 23 West Chicago Avenue, Apt 3606, Chicago, Illinois, 60654, USA.
Department of Otolaryngology and Communication Enhancement, Boston Children's Hospital, Boston, Massachusetts, USA.
Laryngoscope. 2023 Nov;133(11):3152-3157. doi: 10.1002/lary.30659. Epub 2023 Mar 17.
Clinicians increasingly perform balloon dilation of the Eustachian tube (BDET) to treat obstructive Eustachian tube dysfunction (OETD) refractory to medical management. Reported complications have been limited and include patulous Eustachian tube dysfunction (PETD). This multicenter study investigates the incidence of PETD and associated factors.
Consecutive patients at three academic centers undergoing BDET (January 2014-November 2019) for OETD refractory to medical therapy were included. PETD was diagnosed by patient-reported symptoms of autophony of voice and/or breathing. Associated factors studied include age, sex, comorbidities, balloon size, duration of inflation, repeat BDET, and adjunctive procedures.
BDET procedures (n = 295 Eustachian tubes) were performed on 182 patients. Mean age was 38.4 years (SD 21.0; range 7-78) and 41.2% were female. Twenty cases of PETD (6.8% of procedures; 9.3% of patients) occurred following BDET. Risk of PETD did not vary by institution, comorbidities, or adjunctive procedure. Age ≤18 years (adjusted risk ratio [RR] = 3.26; 95% confidence interval [CI]: 1.24, 8.54; p = 0.02), repeat BDET (RR = 3.26; 95% CI: 2.15, 4.96; p < 0.001), and severe preoperative Eustachian tube inflammation (RR = 2.83; 95% CI: 1.10, 7.28; p = 0.03) were associated with increased risk of developing PETD in the multivariable model. Most symptoms were reported as mild or intermittent.
BDET caused PETD symptoms in approximately 7% of dilated Eustachian tubes in this study with increased risk for younger patients and those with severe inflammation or undergoing repeat dilations. Although most cases were self-limited, symptoms can persist. Awareness of risk factors may aid clinicians in limiting this complication.
4 Laryngoscope, 133:3152-3157, 2023.
临床医生越来越多地进行咽鼓管球囊扩张术(BDET)来治疗对药物治疗有抗性的阻塞性咽鼓管功能障碍(OETD)。已报道的并发症有限,包括咽鼓管过度扩张(PETD)。这项多中心研究调查了 PETD 的发生率及其相关因素。
本研究纳入了 2014 年 1 月至 2019 年 11 月期间在三个学术中心因 OETD 而接受 BDET(难治于药物治疗)的连续患者。PETD 通过患者报告的声音和/或呼吸共鸣症状来诊断。研究的相关因素包括年龄、性别、合并症、球囊大小、充气持续时间、重复 BDET 和辅助手术。
对 182 例患者的 295 个咽鼓管进行了 BDET 手术。平均年龄为 38.4±21.0 岁(范围 7-78 岁),其中 41.2%为女性。20 例(6.8%的手术;9.3%的患者)在 BDET 后发生 PETD。PETD 的风险与机构、合并症或辅助手术无关。≤18 岁(调整后的风险比 [RR]为 3.26;95%置信区间 [CI]:1.24,8.54;p=0.02)、重复 BDET(RR 为 3.26;95%CI:2.15,4.96;p<0.001)和严重术前咽鼓管炎症(RR 为 2.83;95%CI:1.10,7.28;p=0.03)与多变量模型中发展 PETD 的风险增加相关。大多数症状被报告为轻度或间歇性。
在这项研究中,BDET 导致大约 7%的扩张咽鼓管出现 PETD 症状,年轻患者和那些炎症严重或接受重复扩张的患者风险更高。尽管大多数病例是自限性的,但症状可能持续存在。了解危险因素可能有助于临床医生限制这种并发症。
4.《喉镜》,133:3152-3157,2023 年。